| 日付 |
時間 |
ソース |
タイトル |
|---|
| 2024/1/08 | 21:00 | EDGAR2 | Form 15-12G - Securities registration termination [Section.. |
| 2024/1/03 | 14:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
| 2023/12/28 | 07:41 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/12/28 | 07:40 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/12/28 | 07:40 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/12/28 | 07:39 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/12/28 | 07:39 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/12/28 | 07:37 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/12/28 | 07:36 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/12/28 | 07:35 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/12/27 | 23:44 | EDGAR2 | Form POS AM - Post-Effective amendments for registration.. |
| 2023/12/27 | 23:43 | EDGAR2 | Form POS AM - Post-Effective amendments for registration.. |
| 2023/12/27 | 23:42 | EDGAR2 | Form S-8 POS - Securities to be offered to employees in.. |
| 2023/12/27 | 22:54 | EDGAR2 | Form 8-K - Current report |
| 2023/12/27 | 22:31 | PRNUS | Lilly Completes Acquisition of POINT Biopharma |
| 2023/12/18 | 22:14 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
| 2023/12/18 | 21:30 | GLOBE | Lantheus and POINT Biopharma Announce Positive Topline.. |
| 2023/12/18 | 20:45 | PRNUS | Lilly Extends Tender Offer to Acquire POINT Biopharma to.. |
| 2023/12/05 | 20:25 | IHMARKETNEWS | Moody’s Reassesses China, GitLab Exceeds Estimates, Twilio.. |
| 2023/12/04 | 21:22 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
| 2023/12/04 | 20:45 | PRNUS | Lilly Extends Tender Offer to Acquire POINT Biopharma to.. |
| 2023/11/17 | 21:05 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
| 2023/11/17 | 20:45 | PRNUS | Lilly Extends Tender Offer to Acquire POINT Biopharma to.. |
| 2023/11/15 | 21:00 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
| 2023/11/15 | 06:33 | PRNUS | Lilly Announces the Receipt of NRC Consent in Connection.. |
| 2023/11/13 | 21:30 | GLOBE | POINT Biopharma Reports Third Quarter 2023 Financial Results.. |
| 2023/11/13 | 21:15 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 2023/11/09 | 07:28 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
| 2023/11/09 | 06:56 | PRNUS | Lilly Announces Extension of Tender Offer to Acquire POINT.. |
| 2023/11/08 | 08:33 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/11/03 | 07:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/11/02 | 05:40 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
| 2023/10/28 | 05:20 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
| 2023/10/13 | 20:11 | EDGAR2 | Form SC 14D9 - Solicitation, recommendation statements |
| 2023/10/04 | 06:24 | EDGAR2 | Form SC14D9C - Written communication relating to third party.. |
| 2023/10/03 | 23:03 | IHMARKETNEWS | Keep An Eye Out: Pre-Market Movers And Recommendations |
| 2023/10/03 | 20:37 | EDGAR2 | Form SC14D9C - Written communication relating to third party.. |
| 2023/10/03 | 20:35 | EDGAR2 | Form 8-K - Current report |
| 2023/10/03 | 19:45 | PRNUS | Lilly to Acquire POINT Biopharma to Expand Oncology.. |
| 2023/9/18 | 21:00 | GLOBE | POINT Biopharma and Athebio Announce Partnership to Develop.. |
| 2023/8/14 | 23:22 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
| 2023/8/14 | 20:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 2023/8/14 | 20:30 | GLOBE | POINT Biopharma Reports Second Quarter 2023 Financial.. |
| 2023/8/14 | 20:21 | EDGAR2 | Form 8-K - Current report |
| 2023/8/04 | 05:05 | EDGAR2 | Form 8-K - Current report |
| 2023/7/31 | 22:00 | GLOBE | ITM and POINT Biopharma Expand Global Supply Agreement for.. |
| 2023/6/26 | 20:45 | GLOBE | POINT Biopharma and AdvanCell to Collaborate in the.. |
| 2023/6/26 | 20:30 | GLOBE | POINT Biopharma Expands Its Research with Next-Generation.. |
| 2023/6/12 | 21:00 | GLOBE | POINT Biopharma Announces Appointment of Dr. Bridget Martell.. |
| 2023/6/07 | 20:00 | GLOBE | POINT Biopharma to Host Virtual Investor Day on Tuesday,.. |
Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
